CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-21 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −5,676 | 0 | ||
| 2022-03-21 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise | +4,611 | 113,674 | ||
| 2022-03-21 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes | −1,461 | $10.98 | $16K | 112,213 |
| 2022-03-21 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −4,611 | 0 | ||
| 2022-03-16 | Megna Michael R Chief Accounting Officer | Option exercise | +775 | 4,199 | ||
| 2022-03-16 | Megna Michael R Chief Accounting Officer | Shares withheld for taxes | −269 | $10.13 | $3K | 3,930 |
| 2022-03-16 | Megna Michael R Chief Accounting Officer | Option exercise · Restricted Share Unit | −775 | 2,323 | ||
| 2022-03-16 | Moat Ross Chief Commercial Officer | Option exercise | +995 | 6,886 | ||
| 2022-03-16 | Moat Ross Chief Commercial Officer | Shares withheld for taxes | −544 | $10.13 | $6K | 6,342 |
| 2022-03-16 | Moat Ross Chief Commercial Officer | Option exercise · Restricted Share Unit | −995 | 2,982 | ||
| 2022-03-16 | Paolini John F. Chief Medical Officer | Option exercise | +1,725 | 31,725 | ||
| 2022-03-16 | Paolini John F. Chief Medical Officer | Shares withheld for taxes | −598 | $10.13 | $6K | 31,127 |
| 2022-03-16 | Paolini John F. Chief Medical Officer | Option exercise · Restricted Share Unit | −1,725 | 5,175 | ||
| 2022-03-16 | Patel Sanj K Chairman & CEO | Option exercise | +6,569 | 6,569 | ||
| 2022-03-16 | Patel Sanj K Chairman & CEO | Shares withheld for taxes | −1,922 | $10.13 | $19K | 4,647 |
| 2022-03-16 | Patel Sanj K Chairman & CEO | Option exercise · Restricted Share Unit | −6,569 | 19,707 | ||
| 2022-03-16 | Ragosa Mark Chief Financial Officer | Option exercise | +872 | 3,979 | ||
| 2022-03-16 | Ragosa Mark Chief Financial Officer | Shares withheld for taxes | −303 | $10.13 | $3K | 3,676 |
| 2022-03-16 | Ragosa Mark Chief Financial Officer | Option exercise · Restricted Share Unit | −872 | 2,616 | ||
| 2022-03-16 | Tessari Eben Chief Operating Officer | Option exercise | +1,964 | 109,744 |
Page 69 of 74 · 1,467 trades